HPV vaccine to be given to boys in England
July 25, 2018Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus
The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …
Pfizer to build $465m sterile injectable plant in Michigan
July 25, 2018Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma
Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …
More antidepressants being prescribed to children in UK
July 25, 2018Research and Development antidepressants, children, mental health, prescription, young people
Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …
Eleven babies dead after Dutch viagra trial
July 25, 2018Research and Development Netherlands, clinical trial, deaths, premature, viagra
A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …
Teva Romania announces new general manager
July 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …
Bristol Myers Squibb announces departure of Chief Commercial Officer
July 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, bristol myers squibb, commerical executive, marketing, sales
Bristol Myers Squibb has announced that Executive Vice President and Chief Commercial Officer, Murdo Gordon, who has been with the …
Celgene’s Revlimid combo meets Phase 3 goal in relapsed/refractory indolent lymphoma
July 24, 2018Manufacturing and Production, Research and Development Celgene, Revlimid, lymphoma, pharma
Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …
Employees protest against shutting down of GSK facility in Bangladesh
July 24, 2018Manufacturing and Production Bangladesh, GSK, manufacturing, protest, union
Employees of the British multinational GlaxoSmithKline (GSK) have led a protest against the shutting down of manufacturing facilities in Bangladesh. …
Scientists launch free, open access, antibiotics database to tackle AMR
July 24, 2018Manufacturing and Production AMR, Antibiotics, Database, academia, resistance
A team of scientists, led by Professor Laura Piddock from the University of Birmingham, have launched a free, open access, …
AstraZeneca jettisons European heart drug rights for $210m
July 24, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma
AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …
First new treatment for reccurent malaria approved in over 60 years
July 23, 2018Manufacturing and Production FDA, GSK, approval, malaria, p.vivax
The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …
The mission against antimicrobial resistance
July 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma
Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …
FDA approves Agios’ oral leukaemia treatment Tibsovo
July 23, 2018Sales and Marketing FDA, agios, approval, pharmaceuticals, tibsovo
The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …
US court overturns Allergan’s controversial attempts to avoid Restasis patent review
July 23, 2018Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma
The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …
Roche join Pfizer and others in price freeze while critics pose questions
July 23, 2018Sales and Marketing Donald Trump, Roche, generics, price freezes
Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …
FDA approves Pfizer biosimilar version of Amgen’s Neupogen
July 23, 2018Sales and Marketing Amgen, FDA, Neupogen, Nivestym, Pfizer, pharma
The FDA has announced its decision to approve Pfizer’s Nivestym, the firm’s biosimilar version of Amgen’s Neupogen (filgrastim), for use …
Chinese premier slams drug maker after vaccine scandal
July 23, 2018Sales and Marketing CCP, China, biotech, scandal, vaccines
Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …
Top Ten most popular articles on Pharmafile.com this week
July 20, 2018Medical Communications GSK, ICR, J&J, JJ, Novartis, Trump, brexit, top 10
As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …
Scottish borders-based Ryboquinn acquires viral delivery comany Nanogenics
July 20, 2018Medical Communications M&A, MA, Scotland, acquisitions, gene therapy, nanogenics, ryboquinn
The Scottish biotech company Ryboquinn has acquired English partner Nanogenics Solutions in a deal worth £4.45 million. The Selkirk-based firm …
FDA explores import strategy in effort to reduce price of drugs
July 20, 2018Medical Communications Drug pricing, Trump, borders, import, the donald
The FDA has been directed to explore ways in which medicines could be safely imported from other countries “in the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
